Technical Analysis for CAPR - Capricor Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 5.05 | -9.01% | -0.50 |
CAPR closed down 9.01 percent on Thursday, April 18, 2024, on 2.96 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| 200 DMA Support | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -9.01% |
| Alert | Time |
|---|---|
| 200 DMA Support | about 6 hours ago |
| Down 10% | about 7 hours ago |
| Down 1 ATR | about 7 hours ago |
| Down 5% | about 7 hours ago |
| 60 Minute Opening Range Breakdown | about 9 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.2212 |
| 52 Week Low | 2.68 |
| Average Volume | 315,727 |
| 200-Day Moving Average | 4.69 |
| 50-Day Moving Average | 5.45 |
| 20-Day Moving Average | 6.42 |
| 10-Day Moving Average | 6.11 |
| Average True Range | 0.49 |
| RSI (14) | 31.51 |
| ADX | 28.56 |
| +DI | 11.52 |
| -DI | 31.68 |
| Chandelier Exit (Long, 3 ATRs) | 5.80 |
| Chandelier Exit (Short, 3 ATRs) | 6.16 |
| Upper Bollinger Bands | 7.40 |
| Lower Bollinger Band | 5.43 |
| Percent B (%b) | -0.19 |
| BandWidth | 30.68 |
| MACD Line | -0.02 |
| MACD Signal Line | 0.22 |
| MACD Histogram | -0.2387 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.50 | ||||
| Resistance 3 (R3) | 6.54 | 6.09 | 6.26 | ||
| Resistance 2 (R2) | 6.09 | 5.72 | 6.07 | 6.18 | |
| Resistance 1 (R1) | 5.57 | 5.50 | 5.35 | 5.53 | 6.10 |
| Pivot Point | 5.13 | 5.13 | 5.02 | 5.11 | 5.13 |
| Support 1 (S1) | 4.61 | 4.76 | 4.39 | 4.57 | 4.00 |
| Support 2 (S2) | 4.16 | 4.53 | 4.14 | 3.92 | |
| Support 3 (S3) | 3.64 | 4.16 | 3.84 | ||
| Support 4 (S4) | 3.60 |
